Related Experiment Video
Updated: Jul 13, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Total cardiovascular risk management
1Division of Nephrology, Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany. prof.e.ritz@t-online.de
Insights
Effective hypertension management requires addressing clustered cardiovascular risk factors. Multifactorial interventions, targeting blood pressure and other risks, are crucial for improving long-term cardiovascular health and reducing morbidity.
Area of Science:
- Cardiology
- Public Health
- Endocrinology
Background:
- Hypertension frequently coexists with other cardiovascular risk factors like insulin resistance, obesity, and dyslipidemia.
- Inadequate blood pressure control (<25% of patients) highlights a significant gap in managing hypertension.
- Global cardiovascular risk is elevated by risk factors, target organ damage, comorbidities, and metabolic syndrome.
Purpose of the Study:
- To emphasize the inadequacy of isolated hypertension treatment.
- To advocate for comprehensive cardiovascular risk assessment and management.
- To highlight the benefits of multifactorial interventions over single-factor approaches.
Main Methods:
- Review of current understanding of cardiovascular risk factors and hypertension management.
- Analysis of the impact of clustered risk factors on cardiovascular morbidity and mortality.
- Evaluation of international treatment guidelines incorporating global cardiovascular risk.
Main Results:
- Multifactorial interventions are highly effective in reducing cardiovascular risk and events, particularly in patients with type 2 diabetes mellitus.
- Small reductions across multiple risk factors can be more beneficial than large reductions in a single factor.
- Individuals with borderline blood pressure and glucose levels face increased cardiovascular disease risk.
Conclusions:
- Isolated treatment of hypertension is insufficient for improving long-term cardiovascular health.
- Active identification and treatment of associated risk factors and target organ damage are essential.
- Adopting a global cardiovascular risk management approach is critical for better patient outcomes.
Abstract:
Hypertension usually clusters with other cardiovascular risk factors, such as insulin resistance, visceral obesity, and dyslipidemia, greatly increasing an individual's risk for cardiovascular morbidity and death. Despite universal recognition that reduction in blood pressure and other cardiovascular risk factors is essential to improving long-term cardiovascular health, <25% of patients diagnosed with hypertension have adequate blood pressure control. Total cardiovascular risk is increased in the presence of risk factors, target organ damage, comorbid conditions, and the metabolic syndrome and may, to some extent, be prenatally determined. Individuals with "borderline" normal blood pressure and blood glucose are also at increased risk for cardiovascular disease, giving rise to the concept of individuals with "prehypertension" and "prediabetes." International treatment guidelines are now incorporating the concept of global cardiovascular risk assessment and management to improve long-term outcomes. Multifactorial intervention has proved to be highly effective at reducing cardiovascular risk and events in patients with type 2 diabetes mellitus, and studies suggest that reducing an array of risk factors by relatively small amounts can be more beneficial than achieving large reductions in a single risk factor. Clearly, isolated treatment of hypertension is no longer sufficient; risk factors and target organ damage need to be actively searched for and treated if long-term cardiovascular health is to be improved.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease III: Medical Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Venous Thrombosis III: Interprofessional Care
Continuous Renal Replacement Therapy